Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2022 | The role of chronic inflammation in clonal hematopoiesis and the development of MDS

Rafael Bejar • 26 Aug 2022
Texas MPN Workshop 2022
Myelodysplastic Syndromes Myeloproliferative Neoplasms

Rafael Bejar, MD, PhD, University of California San Diego, San Diego, CA, discusses the role of chronic inflammation in clonal hematopoiesis and the development of myelodysplastic syndromes (MDS), and further explains how modulating the innate immune system may allow for earlier disease intervention. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Rafael Bejar

CHIP and implications for myeloproliferative neoplasms
Rafael Bejar • 10 Nov 2022
1:32
The role of the innate immune system in MDS pathogenesis
Rafael Bejar • 26 Aug 2022
1:45
The importance of genomic testing in MPNs and other myeloid malignancies
Rafael Bejar • 26 Aug 2022
1:29
Using CHIP to encourage early intervention in disease
Rafael Bejar • 26 Aug 2022

Related Videos

2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
2:06
Understanding the role of inflammation and the immunome in MDS pathophysiology
Shahram Kordasti • 5 Apr 2024
2:53
Immune checkpoint inhibitors in MDS: the i4MDS consortium
Shahram Kordasti • 5 Apr 2024
2:37
Allo-SCT in older patients with MDS: selection, donors, and timing
Didier Blaise • 4 Apr 2024
The content of VJHemOnc is intended for healthcare professionals